INNOVIVA, INC. Stock-Based Compensation
INNOVIVA, INC. (INVA) reported Stock-Based Compensation of $7.31 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-05
- INNOVIVA, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $4.74M, a 95.83% increase year-over-year.
- INNOVIVA, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $2.57M, a 19.56% increase year-over-year.
- INNOVIVA, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $2.50M, a 49.61% increase year-over-year.
- INNOVIVA, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $2.38M, a 48.47% increase year-over-year.
- INNOVIVA, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $9.45M, a 48.29% increase from fiscal 2024.
- INNOVIVA, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $6.37M, a 9.20% increase from fiscal 2023.
- INNOVIVA, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $5.84M, a 20.55% decline from fiscal 2022.
- INNOVIVA, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $7.35M, a 264.25% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $7.31M 10-Q · filed 2026-08-05 | $9.81M derived: sum of 3 quarters · filed 2026-08-05 | $12.19M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $2.57M 10-Q · filed 2026-05-06 | $5.07M derived: sum of 2 quarters · filed 2026-05-06 | $7.45M derived: sum of 3 quarters · filed 2026-05-06 | $9.87M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $4.88M derived: sum of 2 quarters · filed 2026-02-25 | $7.30M derived: sum of 3 quarters · filed 2026-08-05 | $9.45M 10-K · filed 2026-02-25 |
| 2025-09-30 | $2.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $4.80M derived: sum of 2 quarters · filed 2026-08-05 | $6.95M 10-Q · filed 2025-11-05 | $8.62M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $2.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $4.57M 10-Q · filed 2026-08-05 | $6.24M derived: sum of 3 quarters · filed 2026-08-05 | $7.84M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $2.15M 10-Q · filed 2026-05-06 | $3.82M derived: sum of 2 quarters · filed 2026-05-06 | $5.42M derived: sum of 3 quarters · filed 2026-05-06 | $7.07M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $3.28M derived: sum of 2 quarters · filed 2026-02-25 | $4.92M derived: sum of 3 quarters · filed 2026-02-25 | $6.37M 10-K · filed 2026-02-25 |
| 2024-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.25M derived: sum of 2 quarters · filed 2025-11-05 | $4.70M 10-Q · filed 2025-11-05 | $5.98M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $3.10M 10-Q · filed 2025-08-06 | $4.38M derived: sum of 3 quarters · filed 2026-02-25 | $5.82M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $1.46M 10-Q · filed 2025-05-07 | $2.73M derived: sum of 2 quarters · filed 2026-02-25 | $4.17M derived: sum of 3 quarters · filed 2026-02-25 | $5.69M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.72M derived: sum of 2 quarters · filed 2026-02-25 | $4.24M derived: sum of 3 quarters · filed 2026-02-25 | $5.84M 10-K · filed 2026-02-25 |
| 2023-09-30 | $1.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $2.96M derived: sum of 2 quarters · filed 2024-11-06 | $4.56M 10-Q · filed 2024-11-06 | $5.89M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $3.12M 10-Q · filed 2024-07-31 | $4.44M derived: sum of 3 quarters · filed 2025-02-26 | $8.16M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $1.60M 10-Q · filed 2024-05-08 | $2.92M derived: sum of 2 quarters · filed 2025-02-26 | $6.64M derived: sum of 3 quarters · filed 2025-02-26 | $7.99M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $5.04M derived: sum of 2 quarters · filed 2025-02-26 | $6.39M derived: sum of 3 quarters · filed 2025-02-26 | $7.35M 10-K · filed 2025-02-26 |
| 2022-09-30 | $3.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $5.07M derived: sum of 2 quarters · filed 2023-11-01 | $6.02M 10-Q · filed 2023-11-01 | $6.58M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | $1.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $2.30M 10-Q · filed 2023-08-02 | $2.86M derived: sum of 3 quarters · filed 2024-03-05 | $3.40M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | $954.00K 10-Q · filed 2023-05-09 | $1.51M derived: sum of 2 quarters · filed 2024-03-05 | $2.05M derived: sum of 3 quarters · filed 2024-03-05 | $2.52M derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | $554.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-05 | $1.10M derived: sum of 2 quarters · filed 2024-03-05 | $1.57M derived: sum of 3 quarters · filed 2024-03-05 | $2.02M 10-K/A · filed 2024-03-05 |
| 2021-09-30 | $542.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.01M derived: sum of 2 quarters · filed 2022-11-09 | $1.46M 10-Q · filed 2022-11-09 | $1.91M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $470.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $921.00K 10-Q · filed 2022-07-27 | $1.37M derived: sum of 3 quarters · filed 2023-02-28 | $1.81M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $451.00K 10-Q · filed 2022-05-05 | $898.00K derived: sum of 2 quarters · filed 2023-02-28 | $1.34M derived: sum of 3 quarters · filed 2023-02-28 | $1.71M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $447.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $888.00K derived: sum of 2 quarters · filed 2023-02-28 | $1.26M derived: sum of 3 quarters · filed 2023-02-28 | $1.70M 10-K · filed 2023-02-28 |
| 2020-09-30 | $441.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | $816.00K derived: sum of 2 quarters · filed 2021-10-27 | $1.25M 10-Q · filed 2021-10-27 | $1.74M derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-06-30 | $375.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $810.00K 10-Q · filed 2021-07-29 | $1.30M derived: sum of 3 quarters · filed 2022-03-17 | $1.79M derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-03-31 | $435.00K 10-Q · filed 2021-04-28 | $923.00K derived: sum of 2 quarters · filed 2022-03-17 | $1.41M derived: sum of 3 quarters · filed 2022-03-17 | $1.89M derived: sum of 4 quarters · filed 2022-03-17 |
| 2019-12-31 | $488.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-17 | $977.00K derived: sum of 2 quarters · filed 2022-03-17 | $1.45M derived: sum of 3 quarters · filed 2022-03-17 | $2.06M 10-K/A · filed 2022-03-17 |
| 2019-09-30 | $489.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $963.00K derived: sum of 2 quarters · filed 2020-10-28 | $1.57M 10-Q · filed 2020-10-28 | $2.05M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $474.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $1.08M 10-Q · filed 2020-07-29 | $1.56M derived: sum of 3 quarters · filed 2021-02-25 | $691.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $605.00K 10-Q · filed 2020-04-29 | $1.09M derived: sum of 2 quarters · filed 2021-02-25 | $217.00K derived: sum of 3 quarters · filed 2021-02-25 | $1.67M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $486.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$388.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.06M derived: sum of 3 quarters · filed 2021-02-25 | $3.23M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$874.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $578.00K derived: sum of 2 quarters · filed 2019-10-30 | $2.75M 10-Q · filed 2019-10-30 | $5.17M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | $1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $3.62M 10-Q · filed 2019-07-24 | $6.05M derived: sum of 3 quarters · filed 2020-02-19 | $8.52M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | $2.17M 10-Q · filed 2019-05-01 | $4.60M derived: sum of 2 quarters · filed 2020-02-19 | $7.07M derived: sum of 3 quarters · filed 2020-02-19 | $9.49M derived: sum of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | $2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $4.90M derived: sum of 2 quarters · filed 2020-02-19 | $7.33M derived: sum of 3 quarters · filed 2020-02-19 | $9.83M 10-K · filed 2020-02-19 |
| 2017-09-30 | $2.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $4.90M derived: sum of 2 quarters · filed 2018-10-31 | $7.41M 10-Q · filed 2018-10-31 | $9.28M derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-06-30 | $2.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $4.93M 10-Q · filed 2018-07-26 | $6.81M derived: sum of 3 quarters · filed 2019-02-19 | $8.53M derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-03-31 | $2.51M 10-Q · filed 2018-05-04 | $4.38M derived: sum of 2 quarters · filed 2019-02-19 | $6.10M derived: sum of 3 quarters · filed 2019-02-19 | $8.94M derived: sum of 4 quarters · filed 2019-02-19 |
| 2016-12-31 | $1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $3.59M derived: sum of 2 quarters · filed 2019-02-19 | $6.43M derived: sum of 3 quarters · filed 2019-02-19 | $8.30M 10-K · filed 2019-02-19 |
| 2016-09-30 | $1.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $4.56M derived: sum of 2 quarters · filed 2017-11-03 | $6.42M 10-Q · filed 2017-11-03 | $8.07M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | $2.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $4.71M 10-Q · filed 2017-08-08 | $6.36M derived: sum of 3 quarters · filed 2018-02-23 | $7.82M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | $1.86M 10-Q · filed 2017-05-05 | $3.51M derived: sum of 2 quarters · filed 2018-02-23 | $4.98M derived: sum of 3 quarters · filed 2018-02-23 | $6.80M derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | $1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $3.12M derived: sum of 2 quarters · filed 2018-02-23 | $4.94M derived: sum of 3 quarters · filed 2018-02-23 | $6.87M 10-K · filed 2018-02-23 |
| 2015-09-30 | $1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $3.29M derived: sum of 2 quarters · filed 2016-11-03 | $5.22M 10-Q · filed 2016-11-03 | $6.60M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $1.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $3.75M 10-Q · filed 2016-08-04 | $5.13M derived: sum of 3 quarters · filed 2017-02-28 | $9.86M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $1.93M 10-Q · filed 2016-05-05 | $3.31M derived: sum of 2 quarters · filed 2017-02-28 | $8.04M derived: sum of 3 quarters · filed 2017-02-28 | $15.79M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $6.11M derived: sum of 2 quarters · filed 2017-02-28 | $13.86M derived: sum of 3 quarters · filed 2017-02-28 | $27.39M 10-K · filed 2017-02-28 |
| 2014-09-30 | $4.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $12.48M derived: sum of 2 quarters · filed 2015-11-05 | $26.01M 10-Q · filed 2015-11-05 | $32.00M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-06-30 | $7.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $21.28M 10-Q · filed 2015-08-06 | $27.26M derived: sum of 3 quarters · filed 2016-02-24 | $33.71M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-03-31 | $13.54M 10-Q · filed 2015-05-08 | $19.52M derived: sum of 2 quarters · filed 2016-02-24 | $25.96M derived: sum of 3 quarters · filed 2016-02-24 | $33.13M derived: sum of 4 quarters · filed 2016-02-24 |
| 2013-12-31 | $5.98M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $12.43M derived: sum of 2 quarters · filed 2016-02-24 | $19.59M derived: sum of 3 quarters · filed 2016-02-24 | $25.69M 10-K · filed 2016-02-24 |
| 2013-09-30 | $6.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $13.61M derived: sum of 2 quarters · filed 2014-11-04 | $19.70M 10-Q · filed 2014-11-04 | $25.44M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $7.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $13.26M 10-Q · filed 2014-08-07 | $19.00M derived: sum of 3 quarters · filed 2015-02-27 | $24.83M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | $6.09M 10-Q · filed 2014-05-07 | $11.83M derived: sum of 2 quarters · filed 2015-02-27 | $17.66M derived: sum of 3 quarters · filed 2015-02-27 | $23.64M derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | $5.74M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $11.57M derived: sum of 2 quarters · filed 2015-02-27 | $17.55M derived: sum of 3 quarters · filed 2015-02-27 | $23.78M 10-K · filed 2015-02-27 |
| 2012-09-30 | $5.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | $11.81M derived: sum of 2 quarters · filed 2013-11-01 | $18.04M 10-Q · filed 2013-11-01 | $24.25M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | $5.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $12.21M 10-Q · filed 2013-08-01 | $18.42M derived: sum of 3 quarters · filed 2014-03-03 | $26.00M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | $6.24M 10-Q · filed 2013-05-01 | $12.45M derived: sum of 2 quarters · filed 2014-03-03 | $20.02M derived: sum of 3 quarters · filed 2014-03-03 | $25.61M derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | $6.21M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $13.78M derived: sum of 2 quarters · filed 2014-03-03 | $19.38M derived: sum of 3 quarters · filed 2014-03-03 | $24.92M 10-K · filed 2014-03-03 |
| 2011-09-30 | $7.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-31 | $13.16M derived: sum of 2 quarters · filed 2012-10-31 | $18.71M 10-Q · filed 2012-10-31 | $23.40M derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-06-30 | $5.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01 | $11.13M 10-Q · filed 2012-08-01 | $15.83M derived: sum of 3 quarters · filed 2013-02-26 | $20.32M derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-03-31 | $5.54M 10-Q · filed 2012-05-02 | $10.23M derived: sum of 2 quarters · filed 2013-02-26 | $14.73M derived: sum of 3 quarters · filed 2013-02-26 | |
| 2010-12-31 | $4.69M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $9.19M derived: sum of 2 quarters · filed 2013-02-26 | $19.01M 10-K · filed 2013-02-26 | |
| 2010-09-30 | $4.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $14.32M 10-Q · filed 2011-11-02 | ||
| 2010-06-30 | $9.82M 10-Q · filed 2011-08-03 | |||
| 2009-12-31 | $20.00M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |